OPNT Annual Retained Earnings
-$61.68 M
+$3.01 M+4.65%
31 December 2021
Summary:
As of February 5, 2025, OPNT annual retained earnings is -$61.68 million, with the most recent change of +$3.01 million (+4.65%) on December 31, 2021. During the last 3 years, it has risen by +$12.74 million (+17.12%).OPNT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Retained Earnings
-$95.52 M
-$9.92 M-11.58%
30 September 2022
Summary:
As of February 5, 2025, OPNT quarterly retained earnings is -$95.52 million, with the most recent change of -$9.92 million (-11.58%) on September 30, 2022. Over the past year, it has dropped by -$33.09 million (-53.00%).OPNT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.7% | -53.0% |
| 3 y3 years | +17.1% | -49.5% |
| 5 y5 years | -15.9% | -58.6% |
OPNT Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | >+9999.0% | >+9999.0% |
Opiant Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$95.52 M(+11.6%) |
| June 2022 | - | -$85.60 M(+15.9%) |
| Mar 2022 | - | -$73.87 M(+19.8%) |
| Dec 2021 | -$61.68 M(-4.7%) | -$61.68 M(-1.2%) |
| Sept 2021 | - | -$62.43 M(-5.2%) |
| June 2021 | - | -$65.85 M(-2.5%) |
| Mar 2021 | - | -$67.53 M(+4.4%) |
| Dec 2020 | -$64.69 M(+3.0%) | -$64.69 M(+1.1%) |
| Sept 2020 | - | -$64.00 M(-1.1%) |
| June 2020 | - | -$64.73 M(+0.3%) |
| Mar 2020 | - | -$64.51 M(+2.7%) |
| Dec 2019 | -$62.83 M(-15.6%) | -$62.83 M(-1.7%) |
| Sept 2019 | - | -$63.90 M(-14.3%) |
| June 2019 | - | -$74.58 M(-2.1%) |
| Mar 2019 | - | -$76.16 M(+2.3%) |
| Dec 2018 | -$74.42 M(+39.8%) | -$74.42 M(+14.7%) |
| Sept 2018 | - | -$64.88 M(+1.4%) |
| June 2018 | - | -$63.97 M(+2.2%) |
| Mar 2018 | - | -$62.57 M(+3.9%) |
| Dec 2017 | -$53.23 M(-2.5%) | - |
| Oct 2017 | - | -$60.24 M(+10.3%) |
| July 2017 | -$54.60 M(-10.8%) | -$54.60 M(+0.6%) |
| Apr 2017 | - | -$54.27 M(+6.1%) |
| Jan 2017 | - | -$51.14 M(-17.2%) |
| Oct 2016 | - | -$61.79 M(+1.0%) |
| July 2016 | -$61.19 M(+14.6%) | -$61.19 M(+1.8%) |
| Apr 2016 | - | -$60.09 M(-0.7%) |
| Jan 2016 | - | -$60.51 M(-6.2%) |
| Oct 2015 | - | -$64.48 M(+20.8%) |
| July 2015 | -$53.37 M | -$53.37 M(+3.2%) |
| Apr 2015 | - | -$51.73 M(+3.7%) |
| Jan 2015 | - | -$49.88 M(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2014 | - | -$47.11 M(+1.7%) |
| July 2014 | -$46.33 M(+32.9%) | -$46.33 M(+9.9%) |
| Apr 2014 | - | -$42.17 M(+1.3%) |
| Jan 2014 | - | -$41.62 M(+13.8%) |
| Oct 2013 | - | -$36.56 M(+4.9%) |
| July 2013 | -$34.85 M(+45.6%) | -$34.85 M(+30.5%) |
| Apr 2013 | - | -$26.72 M(+4.4%) |
| Jan 2013 | - | -$25.59 M(+2.3%) |
| Oct 2012 | - | -$25.02 M(+4.6%) |
| July 2012 | -$23.93 M(+107.9%) | -$23.93 M(+7.5%) |
| Apr 2012 | - | -$22.26 M(+7.0%) |
| Jan 2012 | - | -$20.80 M(+28.2%) |
| Oct 2011 | - | -$16.23 M(+41.0%) |
| July 2011 | -$11.51 M(+455.4%) | -$11.51 M(+31.6%) |
| Apr 2011 | - | -$8.75 M(+161.3%) |
| Jan 2011 | - | -$3.35 M(+42.3%) |
| Oct 2010 | - | -$2.35 M(+13.6%) |
| July 2010 | -$2.07 M(+3653.4%) | -$2.07 M(+30.5%) |
| Apr 2010 | - | -$1.59 M(+15.9%) |
| Jan 2010 | - | -$1.37 M(+942.8%) |
| Oct 2009 | - | -$131.40 K(+138.0%) |
| July 2009 | -$55.20 K(-34.1%) | -$55.20 K(-42.9%) |
| Apr 2009 | - | -$96.70 K(+4.8%) |
| Jan 2009 | - | -$92.30 K(+3.7%) |
| Oct 2008 | - | -$89.00 K(+6.3%) |
| July 2008 | -$83.70 K(+27.4%) | -$83.70 K(+16.9%) |
| Apr 2008 | - | -$71.60 K(+2.6%) |
| Jan 2008 | - | -$69.80 K(+5.1%) |
| Oct 2007 | - | -$66.40 K(+1.1%) |
| July 2007 | -$65.70 K | -$65.70 K(+22.3%) |
| Apr 2007 | - | -$53.70 K(+30.7%) |
| Jan 2007 | - | -$41.10 K |
FAQ
- What is Opiant Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual retained earnings year-on-year change?
- What is Opiant Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly retained earnings year-on-year change?
What is Opiant Pharmaceuticals annual retained earnings?
The current annual retained earnings of OPNT is -$61.68 M
What is the all time high annual retained earnings for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual retained earnings is -$55.20 K
What is Opiant Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, OPNT annual retained earnings has changed by +$3.01 M (+4.65%)
What is Opiant Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of OPNT is -$95.52 M
What is the all time high quarterly retained earnings for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly retained earnings is -$41.10 K
What is Opiant Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, OPNT quarterly retained earnings has changed by -$33.09 M (-53.00%)